The "Gold Sodium Thiosulfate (CAS 10233-88-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.This ...

Equities research analysts at Wedbush upped their Q1 2025 earnings estimates for shares of Fennec Pharmaceuticals in a ...

Analysts at HC Wainwright upped their Q1 2025 EPS estimates for Fennec Pharmaceuticals in a report issued on Tuesday, March ...

Over-Year, and Generated PEDMARK® Q4 2024 Net Product Sales of $7.9 Million ~ ~ Delivered Q4 2024 EBITDA Loss of $0.6 Million and Company Has $26.6 Million in Cash, ...

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year.

~ Achieved Full-Year PEDMARK ® Net Product Sales of $29.6 Million, Up 40% Year-Over-Year, and Generated PEDMARK ® Q4 2024 Net Product Sales of $7.9 Million ~ ~ Delivered Q4 2024 EBITDA Loss of $0.6 ...

After hours: March 5 at 4:13:34 p.m. EST ...

After hours: March 11 at 4:05:05 PM EDT Loading Chart for FENC ...